Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study

OBJECTIVES: To analyze the efficacy and safety of dolutegravir/rilpivirine (DTG/RPV) in HIV-infected patients who switched from any other antiretroviral therapy (ART). METHODS: Open-label, multicenter study including patients who switched to DTG/RPV between February 2015 and February 2016. Efficacy...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Int Assoc Provid AIDS Care
Päätekijät: Palacios, Rosario, Mayorga, M., González-Domenech, C. M., Hidalgo-Tenorio, C., Gálvez, C., Muñoz-Medina, L., de la Torre, J., Lozano, A., Castaño, M., Omar, M., Santos, Jesús
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2018
Aiheet:
Short Communication
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6748491/
https://ncbi.nlm.nih.gov/pubmed/29529910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2325958218760847
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia